These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6894381)

  • 61. Effect of pirenzepine on postoperative gastric secretion.
    Urakawa T; Nagahata Y; Kawakita N
    Kobe J Med Sci; 1993 Apr; 39(2):69-79. PubMed ID: 8411909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of alpha1-antitrypsin deficiency in patients with gastric or duodenal ulcer.
    Andre F; Andre C; Lambert R; Descos F
    Biomedicine; 1974 May; 21(5):222-4. PubMed ID: 4547980
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibition of gastrin secretion by pirenzepine (LS 519) in treatment of gastric ulcer.
    Tatsuta M; Itoh T; Okuda S; Tamura H; Baba M; Yamamura H
    Scand J Gastroenterol; 1981; 16(2):269-71. PubMed ID: 6895560
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Experimental research on correlations between the carbonic anhydrase activity of the gastric mucosa, ulcer and pregnancy, in female rats].
    Dobrescu D; Cicotti A; Lungu-Mihailescu R
    Arch Fr Mal App Dig; 1971; 60(8):427-32. PubMed ID: 5001234
    [No Abstract]   [Full Text] [Related]  

  • 66. [Arylsulfatase in human gastric mucosa].
    Antonucci A; Cavallini M
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2404-7. PubMed ID: 41534
    [No Abstract]   [Full Text] [Related]  

  • 67. [Uropepsin activity in children aged 3 to 14 years with gastric and duodenal ulcer].
    Mrygłodowicz A
    Pediatr Pol; 1978 Jan; 53(1):49-54. PubMed ID: 246513
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.
    Jaup BH; Stockbrügger RW; Dotevall G
    Scand J Gastroenterol Suppl; 1980; 66():89-94. PubMed ID: 6941380
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of gastrozepin on the rate of gastrointestinal tract evacuation in patients with peptic ulcer of the duodenum].
    Likov AF; Guba ES; Belokon' SN; Dzhangirov IP
    Ter Arkh; 1986; 58(2):35-7. PubMed ID: 3754656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy].
    Esedov EM; Muradova VR; Mamaev SN
    Ter Arkh; 1999; 71(2):19-22. PubMed ID: 10222547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The characteristics of gastrozepin pharmacokinetics in patients with gastric and duodenal peptic ulcers].
    Loginov AS; Sil'vestrova SIu; Bendikov EA; Giliadova LA
    Farmakol Toksikol; 1990; 53(1):43-5. PubMed ID: 2328798
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Inhibition of nocturnal acid secretion by pirenzepine (author's transl)].
    Dammann HG; Simon B; Müller P; Krüger HJ
    Arzneimittelforschung; 1982; 32(3):309-10. PubMed ID: 7044387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of gastric acid secretion by pirenzepine (LS 519) in man.
    Stockbrügger R; Jaup B; Hammer R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):615-20. PubMed ID: 493865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A dried aspen bark extract in the experimental therapy of gastric peptic ulcer].
    Krylova SG; Zueva EP; Razina TG; Turetskova VF; Amosova EN
    Eksp Klin Farmakol; 2000; 63(2):44-7. PubMed ID: 10834093
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Enzymatic activity in the enterolysed portions of the human gastric mucosa in peptic ulcer and the effect of bile].
    Ivanov GG
    Vopr Med Khim; 1979; 25(6):691-4. PubMed ID: 516530
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Action of the vagus nerve on the carbonic anhydrase content of human gastric mucosa].
    Banciu T; Berinde L; Puşcaş I; Prodan P; Rocsin M; Paraliov T
    Stud Cercet Med Interna; 1973; 14(1):41-6. PubMed ID: 4219459
    [No Abstract]   [Full Text] [Related]  

  • 80. Luminal acid in water-immersion stress and the antiulcer effect of axetazolamide in the rat gastric mucosa.
    Gutierrez-Cabano CA
    Acta Gastroenterol Latinoam; 1999; 29(1):25-31. PubMed ID: 10435191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.